Domov › Metastatická rakovina › Kalifornia › San Francisco

Klinické štúdie Metastatická rakovina v meste San Francisco, CA

28 štúdií pre Metastatická rakovina hľadá účastníkov v zariadeniach v meste San Francisco a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Prebieha náborFáza 1/2

Avenzo Therapeutics Recruiting Site, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07193511

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Prebieha náborFáza 1/2

University of California San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05287945

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Prebieha náborFáza 3

UCSF at China Basin, San Francisco
UCSF at Mount Zion, San Francisco
UCSF at Parnassus, San Francisco
a 1 ďalších

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

Intratumoral N17350 in Advanced Solid Tumors

Prebieha náborFáza 1/2

University of California, San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07339176

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Prebieha náborFáza 1

UCSF Medical Center at Mount Zion, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06915753

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Prebieha náborFáza 3

UCSF Medical Center at Mission Bay, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Prebieha náborFáza 3

Kaiser Permanente, San Francisco
UCSF Medical Center at Mission Bay, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Prebieha náborFáza 1/2

UCSF Medical Center at Mission Bay ( Site 0034), San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06863272

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Prebieha náborFáza 1/2

University of California, San Francisco (UCSF), San Francisco

Vek 18 a viac · Ženy · Aktualizované 3. 9. 2026 · NCT04802759

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Prebieha náborFáza 1

University of California San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT04913285

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1/2

University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Prebieha náborFáza 1/2

Crinetics Study Site, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 7. 2026 · NCT07129252

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

Prebieha náborFáza 2

University of California, San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT07043608

Imaging of Solid Tumors Using 18F-TRX

Prebieha náborFáza 1

University of California, San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 7. 2026 · NCT06942104

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Prebieha náborFáza 1/2

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

Vek 12 a viac · Všetky pohlavia · Aktualizované 14. 7. 2026 · NCT05533697

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Prebieha náborFáza 1

University of California San Francisco, San Francisco

Vek 18 a viac · Muži · Aktualizované 9. 7. 2026 · NCT07103018

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1

Exelixis Clinical Site #5, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 6. 2026 · NCT06952010

Combination Therapy in Cancers With Mutations in DNA Repair Genes

Prebieha náborFáza 1

University of California, San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 6. 2026 · NCT05694715

Imaging of Solid Tumors Using FAP-2286

Prebieha náborFáza 1

University of California, San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT04621435

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Prebieha náborFáza 1

University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT06917079

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Prebieha náborFáza 1/2

University of California San Francisco (UCSF), San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT06413680

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Prebieha náborFáza 2/3

University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 4. 2026 · NCT06947928

Comparison of Whole Body DWI to FDG PET

Prebieha nábor

University of California, San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 4. 2026 · NCT06630845

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Prebieha náborFáza 1/2

University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 3. 2026 · NCT06244771

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Prebieha náborFáza 1

University of California San Francisco-Benioff Children's Hospital, San Francisco

Vek 1 až 40 · Všetky pohlavia · Aktualizované 12. 3. 2026 · NCT05292664

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Prebieha náborFáza 1

University of California San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT06778863

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Prebieha náborObservačná štúdia

Massive Bio SYNERGY-AI site, San Francisco

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

Prebieha náborFáza 1

University of California, San Francisco, San Francisco

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2025 · NCT05107674

Štúdie Metastatická rakovina v iných mestách

Iné štúdie v San Francisco

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.